Disabling an Integral CTL Epitope Allows Suppression of Autoimmune Diabetes by Intranasal Proinsulin Peptide
Journal of Clinical Investigation - United States
doi 10.1172/jci17166
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2003
Authors
Publisher
American Society for Clinical Investigation